StockStory.org on MSN

NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) reported Q3 CY2025 results , with sales up 11.9% year on year ...
Healio

NIH awards $3M for study of skin punch biopsy test for Parkinson’s risk

The NIH has awarded a $3 million research grant to CND Life Sciences to initiate a 3-year multicenter study to evaluate the validity of a skin punch biopsy test to determine risk for Parkinson’s ...
HealthDay

Gene Expression Profile Test IDs Patients Who Can Skip SLNB in Melanoma

The combined clinicopathological factors and gene-expression profile (CP-GEP) test can identify which patients with p ...

Prostate cancer ‘one-day diagnostics’ trialled on NHS to revolutionise care

Prostate cancer could be diagnosed within days using “one stop shops” that harness artificial intelligence, the NHS has ...